Connect with us

Health

Greece Reports Rising West Nile Virus Cases as Europe Faces Active Summer Outbreak

Published

on

Greece is experiencing a sharp rise in West Nile virus infections, with health authorities warning that the mosquito-borne disease is spreading more widely than confirmed case numbers suggest. The country, alongside Italy, has recorded the highest level of virus activity in Europe this season.

Greece’s National Public Health Organisation reported 23 new infections during the past week. Since the start of the transmission season in spring through August 5, the country has confirmed 65 cases. Of those, 54 patients developed severe neurological complications, including encephalitis, meningitis or acute flaccid paralysis, while 11 experienced mild symptoms or no significant effects on the central nervous system.

The outbreak has resulted in six deaths, all involving patients over the age of 65 who suffered severe neurological illness.

Health officials cautioned that the confirmed figures represent only a fraction of the virus’s actual spread. Based on seroepidemiological data, authorities estimate that for every patient diagnosed with serious neurological disease, about 140 other people may have been infected without being diagnosed because they developed mild symptoms or none at all.

The virus continues to circulate across several regions of Greece. Cases have been identified in 25 municipalities covering Attica, Thessaly and Central Macedonia. The highest concentration has been recorded in Attica, where public health officials say transmission has been particularly intense this summer.

Of the 65 confirmed patients, 20 remain in hospital. Twelve are receiving treatment in general wards, while eight are in intensive care units. Thirty-eight patients have been discharged, and one person did not require hospital treatment.

See also  World Marks 37th World AIDS Day as Funding Cuts Raise Fears of Setbacks in Global Fight Against HIV

The outbreak is part of a broader rise in West Nile virus activity across Europe. According to the European Centre for Disease Prevention and Control (ECDC), human infections have also been confirmed in Italy, Romania, France, North Macedonia, Spain and Germany through July 29.

The ECDC has identified 49 affected areas across seven European countries. Italy accounts for the largest number, with 30 affected areas, followed by Greece with eight. Romania has four affected areas, while France, North Macedonia and Spain each have two, and Germany has one.

Italy has also reported the highest number of confirmed human infections in Europe this season, with 94 cases. North Macedonia and Spain have each recorded seven cases, Romania has reported five, France two and Germany one.

West Nile virus is transmitted primarily through the bites of infected mosquitoes. Most infected people experience either mild flu-like symptoms or no symptoms at all. In a small proportion of cases, particularly among older adults and people with underlying health conditions, the infection can lead to serious neurological disease.

Public health authorities are urging residents and visitors to reduce mosquito exposure by using insect repellent, wearing protective clothing and eliminating standing water where mosquitoes breed as surveillance and prevention efforts continue throughout the summer.

Health

West Nile Virus Cases Surge in Greece as Death Toll Reaches 19

Published

on

West Nile virus infections in Greece have increased sharply, with 75 new locally acquired cases reported in one week, bringing the total number of infections recorded during the 2026 transmission season to 232.

The latest figures from the National Public Health Organisation (EODY) show that 165 patients developed neurological complications affecting the central nervous system. These included conditions such as encephalitis, meningitis and acute flaccid paralysis.

Another 67 patients experienced milder illness or had no neurological symptoms. As of August 26, Greece had recorded 19 deaths linked to the virus. All of those who died were aged over 65.

Hospitals are also dealing with a significant number of patients. EODY reported that 73 people were receiving hospital treatment, including 26 in intensive care units and one in a high-dependency unit. A total of 124 patients have been discharged.

Attica sees major increase

The Attica region has emerged as the main centre of the outbreak, with authorities reporting particularly intense virus circulation compared with previous years.

Cases have been identified across 61 municipalities, 18 regional units and five regions: Attica, Thessaly, Central Macedonia, the Peloponnese and Central Greece.

Eastern Attica has been among the hardest-hit areas. Spata-Artemida has recorded 17 cases, including 15 involving the central nervous system. Markopoulo Mesogaias has reported 13 cases, while infections have also been detected in Vari-Voula-Vouliagmeni, Agia Paraskevi, Pallini and Halandri.

Thessaly has also experienced substantial transmission. Larissa has recorded 21 cases, with additional infections reported in Karditsa, Palamas, Sofades, Kileler, Tempi, Tyrnavos and Farsala.

Central Macedonia has reported infections in several areas, including parts of Imathia, Thessaloniki, Pella, Pieria and Serres.

See also  E-Cigarette Use Rises as European Teens Turn Away from Alcohol and Drugs, Survey Finds

Authorities identify new risk areas

EODY has designated several additional municipalities as high-risk areas based on epidemiological and geographical factors, even though no human cases had been identified there at the time of assessment.

The areas include Heraklion of Attica, Nea Smyrni, Nea Filadelfia-Nea Chalkidona, Dafni-Ymittos, Amfipoli and Thasos.

Authorities have also detected signs of virus circulation among horses and other equidae. Recent infections were found in nine clusters across Eastern Attica, Western Athens, Drama, Preveza and the Thessaloniki metropolitan area.

EODY expects more cases to be identified in the coming weeks, both in areas already affected and in new locations. It also warned that recent figures could rise as diagnoses and official notifications can occur several days after symptoms begin.

The surge has placed Greece on heightened alert as health authorities continue monitoring the spread of the mosquito-borne disease.

Continue Reading

Health

Study Finds Eating Disorders Have Complex Genetic Links Beyond Body Weight

Published

on

Eating disorders may have a stronger biological component than previously understood, with new research suggesting that genetic factors linked to binge eating and anorexia nervosa are distinct from those that influence body weight.

Researchers at Sweden’s Karolinska Institutet examined genetic information from thousands of people to investigate factors associated with eating disorder behaviours. Their findings suggest that these conditions cannot be explained solely by body image, weight or metabolism.

The study, published in Nature Mental Health, included nearly 40,000 people with binge-eating behaviour and about 25,000 people with anorexia nervosa. Researchers compared them with more than 1.2 million people without eating disorders.

The team identified genetic variations statistically associated with a greater likelihood of developing the conditions. Six genetic markers were linked to binge eating, while eight were associated with anorexia nervosa. Two of the markers connected to anorexia had not previously been identified.

Lu Yi, principal researcher at Karolinska Institutet’s Department of Medical Epidemiology and Biostatistics, said the findings showed that eating disorders were not simply related to body weight.

The researchers noted that many genetic variants associated with eating disorders differ from those that influence how much a person weighs. This points to a more complicated biological basis for the conditions.

Scientists can combine the effects of multiple genetic markers to produce what is known as a polygenic risk score. Such a score reflects the number and strength of genetic variants associated with a particular condition.

However, the researchers stressed that these genetic markers remain weak predictors when used on their own. Other biological, psychological and environmental factors would need to be considered when assessing an individual’s risk.

See also  Albania Imposes New Rule to Retain Medical Graduates Amid Health Worker Shortage Crisis

The study also identified links between genetic markers associated with eating disorders and other health and behavioural characteristics.

Some genetic markers connected to binge eating were also associated with traits involving impulse control, including smoking and risk-taking behaviour. They were also linked to higher body mass index and attention-deficit hyperactivity disorder.

Anorexia-related markers showed stronger genetic associations with obsessive-compulsive disorder.

The researchers said these differences suggest that binge eating and anorexia nervosa may involve partly separate biological mechanisms, even though both are classified as eating disorders.

Lisa Dinkler, an assistant professor at Karolinska Institutet, said the findings could eventually contribute to more targeted treatment approaches based on the specific characteristics of different eating disorders.

Eating disorders affect millions of people worldwide and are associated with serious risks to physical and mental health. They commonly involve disturbed eating patterns, intense concerns about food, weight or body shape, and significant effects on daily functioning.

Researchers said the findings could help shift the understanding of eating disorders away from a narrow focus on body weight and toward a broader view that considers distinct biological pathways.

Continue Reading

Health

New RNA Modification Could Make mRNA Medicines More Powerful, Scientists Say

Published

on

A small chemical change to messenger RNA could help future vaccines and medicines produce more therapeutic proteins inside cells, according to researchers at Johns Hopkins Medicine.

Scientists have identified a potential alternative to the RNA modification widely used in current mRNA technology. Their research suggests that replacing N1-methylpseudouridine, known as m1Ψ, with a naturally occurring modification called N4-acetylcytidine, or ac4C, could increase the speed at which cells translate mRNA into proteins.

The findings were published in the journal Nature and could eventually have implications for vaccines and treatments being developed for infectious diseases, cancer and autoimmune conditions.

The current leading mRNA platform uses m1Ψ, which became widely known through the COVID-19 vaccines. Researchers are now investigating the technology for a much broader range of medical applications.

The Johns Hopkins team compared the two modifications in cultured human dendritic cells and mouse liver cells. They found that ribosomes, the structures responsible for reading mRNA and producing proteins, moved considerably faster along ac4C-modified mRNA.

“Our results show that ac4C causes cells to produce more therapeutic proteins than the industry standard mRNA platform,” said Bin Wu, an associate professor of biophysics and biophysical chemistry at the Johns Hopkins University School of Medicine.

The researchers found that ribosomes travelled almost twice as fast on ac4C-modified mRNA compared with m1Ψ-modified mRNA.

Wu compared the difference to traffic congestion. When ribosomes move more slowly, they can build up along an mRNA strand and create what researchers describe as a molecular traffic jam. Faster movement could allow more ribosomes to process the same strand efficiently, increasing protein production.

See also  Mothers’ Genes May Indirectly Influence Children’s Weight, New Study Finds

The potential benefit could be significant for mRNA medicines. These treatments work by giving cells temporary genetic instructions to produce specific proteins. The amount of protein generated can influence whether a treatment reaches the level needed to produce a therapeutic effect.

If ac4C allows cells to produce more protein from the same amount of mRNA, future therapies could potentially require smaller doses. That could reduce the amount of material needed for some treatments while improving their effectiveness.

Researchers point out that more than 170 RNA modifications are known to exist, but only a limited number have been extensively investigated for use in mRNA therapies.

The discovery could open another area of research as scientists seek to improve the performance of mRNA technology. Potential applications include vaccines against infectious diseases, cancer treatments that activate immune responses and therapies designed to modify immune activity in autoimmune disorders.

However, ac4C is still at an experimental stage. The findings have so far been demonstrated in laboratory and animal cells, meaning further studies will be needed to determine whether the modification is safe and effective in living organisms.

If future research confirms the results, the chemical change could become an important step in improving the next generation of mRNA-based medicines.

Continue Reading

Trending